Neoantigen Peptides Manufacturing Market Share, Size, Growth and Forecast to 2031

The Neoantigen Peptides Manufacturing Market is expected to grow at a 16.0 % CAGR during the forecast period for 2023-2031.

Neoantigens are newly generated peptides that are capable of inducing tumour-specific T cell recognition. These are created through somatic mutations. Researchers and physicians have recently used next-generation sequencing technology to detect neoantigens and develop tailored cancer immunotherapies. Neoantigens are short peptides derived from tumour-specific somatic mutations. These peptides bind to HLA (Human Leucocyte Antigen) molecule to be recognized by T-Cell Receptors (TCRs), which further activate the immune system for specific cancer cells. In manufacturing neoantigen-based vaccines, personalized neoantigen peptides are synthesized, which helps induce the T-cell population. This new type of immunotherapy can produce a strong and specific immune response and draw out stable therapeutic effects. As a result, personalized neoantigen peptide vaccines are designed to train a patient's immune system to target and kill tumour cells. Hence they are used to develop vaccines and immunotherapies against cancer cells. These significant neoantigens can control tumour outgrowth and felicitate cellular transformation.

Synthetic peptides are a recognized model of cancer vaccine delivery, but creating the peptides for each patient rapidly and inexpensively remains difficult. The rising number of clinical trials, the growth in cancer and chronic illness cases, and the necessity for long-term therapy for these diseases are all prominent market factors for Neoantigen peptide synthesis. Furthermore, advances in biotechnology research will help researchers better understand individualized neoantigen peptides. Increased external investment in cancer drug research and development, on the other hand, drives the market upward. On the other hand, costly designing and development of personalized cancer therapeutics and delayed clinical trials due to the COVID-19 impact will restrain the market.

Market Segmentation

The Neoantigen Peptides Manufacturing Market is segmented into the Scale of operations, end-users, and region. The scope of operation segment comprises research/preclinical, clinical, and commercial. The market is segmented into pharmaceutical/vaccine developer companies, contract research organizations (CRO), and academic & research institutes by end-users. Region-wise, the market is studied across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The North American market can witness rapid growth during the forecast period (2020-2030) due to the well-established healthcare infrastructure, growing research regarding Peptide synthesis, and the rising government efforts to develop personalized vaccines.

Competitive Landscape

Some of The Key Players in The Neoantigen Peptides Manufacturing Market:

CPC Scientific Inc
Polypeptide group
Genscript Biotech
Kaneka Eurogentec S.A.
Vivitide
Almac
BCN Peptides
Creative Peptides
Pepscan
Provepharm
Creosalus
Gyros Protein Technologies
AnaSpec
Other Prominent Players

The Neoantigen Peptides Manufacturing Market Report Scope

Report Attribute	Specifications
Growth Rate CAGR	CAGR of 16.0 % from 2023 to 2031
Quantitative Units	Representation of revenue in US$ Million, Volume (Unit), and CAGR from 2023 to 2031
Historic Year	2019 to 2022
Forecast Year	2023-2031
Report Coverage	The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends
Segments Covered	By Scale of Operations, by End-User
Regional Scope	North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country Scope	U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia
Competitive Landscape	CPC Scientific Inc, Polypeptide group, Genscript Biotech, Kaneka Eurogentec S.A., Vivitide, Almac, BCN Peptides, Creative Peptides, Pepscan, Provepharm, Creosalus, AnaSpec, Gyros Protein Technologies, Other Prominent Players
Customization Scope	Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.
Pricing and Available Payment Methods	Explore pricing alternatives that are customized to your particular study requirements.